Quantum-Safe Pharma Intensive – Live Online (Americas), June 2027
An eight-hour workshop for pharma and biotech teams. Work validation, record retention, and trading-partner constraints into a migration plan ready for quality review.
IT quality and computerized system validation leads, manufacturing and laboratory systems owners, serialization and supply chain leads, regulatory operations, and CISOs and security architects who will own the plan. Send a mixed group from one company. The person who owns the validation master plan rarely owns the TLS configuration or the trading-partner credentials. Bring at least one person from quality assurance. Many of the sequencing decisions in this workshop are change control decisions. If you run a health system or build medical devices, the Quantum-Safe Healthcare Intensive is the working day for your estate.
What you will cover
- Build a cryptographic inventory from your list of GxP systems and their validation records, and mark what you control against what a vendor, regulator, or trading partner controls
- Classify a cryptographic change by GxP risk, choose the testing and evidence your change control procedure requires, and explain the choice to an inspector
- Design validated systems so you can change an algorithm once, in qualified infrastructure, and regression-test the applications that depend on it
- Plan how signed records stay verifiable through retention periods of 25 years or more, without breaking audit trails or ALCOA+ expectations
- Map the cryptography you depend on and cannot change yourself, from FDA and EMA submission gateways to DSCSA trading-partner credentials and serialization data standards
- Write post-quantum and crypto-agility clauses into supplier contracts and quality agreements with contract development and manufacturing organizations (CDMOs), and add matching entries to user requirements specifications
The format
1 day, 8 hours. Delivered live in two half-day sessions, Tuesday and Wednesday, 15:00 to 19:00 UTC each day, for participants in the Americas. Included: Course handbook, certificate of completion.
Full outline, modules, and delivery details are on the course page, together with a justification letter you can adapt if you need internal approval to attend: Quantum-Safe Pharma Intensive.
Our confirmation guarantee. This course needs eight participants. If it has not reached eight twenty-one days before the start date, we cancel it, refund you in full, and add a credit toward any course at the same price or lower. If you do not hear from us, the course is going ahead.
This course is educational and informational, and is not legal, compliance, or engineering advice.
